Uccc-Bn-19-01- Detecting Tumor-Derived Cell-Free Dna In Csf Of Glioblastoma Patients And Determining The Correlation To Tumor Burden And Prognosis
Posted Date: Sep 11, 2020
- Investigator: Jonathan Forbes
- Specialties: Cancer, Oncology
- Type of Study: Observational/Survey
The purpose of this study is to assess the feasibility of detecting circulating tumor-derived cell-free DNA (ctDNA) in CSF extracted from glioblastoma patients at pre-specified clinical time points either during surgical resection or via lumbar puncture.
Criteria:
To Be Eligible: Must Have Mri Imaging Highly Suggestive Of A Resectable Glioblastoma Within 60 Days, History Of Lumbar Fusion At The L2 To L4 Levels, No Use Of Anti-Coagulants, No Other Malignancy Requiring Chemo Within 5 Years, No Bmi>40
Keywords:
Brain Cancer, Glioblastoma
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com